Primary Site >> Colorectal Cancer
Gene >> GLA
| 1. | |||||||||||
| Journal: | Bioconjug Chem. 1993 Jan-Feb;4(1):10-8. | ||||||||||
| Title: | Enhanced in vitro tumor cell retention and internalization of antibody derivatized with synthetic peptides. | ||||||||||
| Author: | Anderson, D C|Manger, R|Schroeder, J|Woodle, D|Barry, M|Morgan, A C|Fritzberg, A R | ||||||||||
| PMID: | 8431507 | ||||||||||
| 2. | |||||||||||
| Journal: | Prostaglandins Leukot Essent Fatty Acids. 2003 Jan;68(1):9-16. | ||||||||||
| Title: | Association between E-cadherin expression by human colon, bladder and breast cancer cells and the 13-HODE:15-HETE ratio. A possible role of their metastatic potential. | ||||||||||
| Author: | Pasqualini, M E|Heyd, V L|Manzo, P|Eynard, A R | ||||||||||
| PMID: | 12538085 | ||||||||||
| 3. | |||||||||||
| Journal: | Prostaglandins Leukot Essent Fatty Acids. 2005 Apr;72(4):273-8. | ||||||||||
| Title: | Gamma-Linolenic acid regulates the expression and secretion of SPARC in human cancer cells. | ||||||||||
| Author: | Watkins, Gareth|Martin, Tracey A|Bryce, Richard|Mansel, Robert E|Jiang, Wen G | ||||||||||
| PMID: | 15763439 | ||||||||||
| 4. | |||||||||||
| Journal: | PLoS One. 2015 Apr 17;10(4):e0123256. | ||||||||||
| Title: | Growth inhibitory effect of polyunsaturated fatty acids (PUFAs) on colon cancer cells via their growth inhibitory metabolites and fatty acid composition changes. | ||||||||||
| Author: | Zhang, Chengcheng|Yu, Haining|Ni, Xiaofeng|Shen, Shengrong|Das, Undurti N | ||||||||||
| PMID: | 25886460 | ||||||||||
| 5. | |||||||||||
| Journal: | Arch Med Sci. 2015 Oct 12;11(5):1081-94. | ||||||||||
| Title: | Polyunsaturated fatty acids trigger apoptosis of colon cancer cells through a mitochondrial pathway. | ||||||||||
| Author: | Zhang, Chengcheng|Yu, Haining|Shen, Yuzhen|Ni, Xiaofeng|Shen, Shengrong|Das, Undurti N | ||||||||||
| PMID: | 26528354 | ||||||||||
| 6. | |||||||||||
| Journal: | Int J Cancer. 2016 Apr 1;138(7):1754-64. | ||||||||||
| Title: | Perioperative treatment with the new synthetic TLR-4 agonist GLA-SE reduces cancer metastasis without adverse effects. | ||||||||||
| Author: | Matzner, Pini|Sorski, Liat|Shaashua, Lee|Elbaz, Ely|Lavon, Hagar|Melamed, Rivka|Rosenne, Ella|Gotlieb, Neta|Benbenishty, Amit|Reed, Steve G|Ben-Eliyahu, Shamgar | ||||||||||
| PMID: | 26453448 | ||||||||||